Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 7

National Institutes of Health (NIH)

Status and phase: Completed; Phase 1

Conditions: Opioid-Related Disorders; Substance-Related Disorders

Treatments: Drug: Lofexidine

Study type: Interventional

Funder types: Other; NIH

Identifiers

NCT00000358

NIDA-3-0012-7

Y01-3-0012-7

Details and patient eligibility

About

The purpose of this study is to determine the safety of lofexidine in the treatment of opiate withdrawal. Preliminary data will also be obtained to assess the ability of lofexidine to alleviate opiate withdrawal signs and symptoms.

Sex: All

Ages: 21 to 59 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Please contact site for information.